Patient Care

Clinical Session: “The New C. Diff


 

JOHN G. BARTLETT, MD, professor of medicine in the Department of Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, mesmerized a standing-room-only crowd of more than 500 at his lecture about the increase of Clostridium difficile in U.S. hospitals.

C. diff incidence has more than doubled since the mid-1990s, to more than 160 cases per 100,000 patients, and currently outnumbers the annual total of MRSA cases in the U.S., according to Dr. Bartlett, one of the foremost scholars on the subject. For hospitalists encountering patients with questions about the disease and where it comes from, Dr. Bartlett encouraged providers to punt that question: “The fact is, we don’t know most of the time.”

Most patients acquire C. diff during a hospital stay (74%) or a previous hospital stay (21%), and research shows the longer patients stay in the hospital, the more likely they are to acquire the disease.

If your lab does PCR, it’s the best test currently available.

—John G. Bartlett, professor, Department of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore

“It’s embedded in the fabric of hospitals,” Dr. Bartlett said. “The longer you are in the hospital, the more likely you are to get colonized.”

Prevention guidelines include:

  • Hand hygiene;
  • Advocate gloves and gowns;
  • Patients with C. diff should be in single rooms;
  • Maintain precautions until diarrhea resolves; and
  • Clean with chlorine antiseptic.

Dr. Bartlett was excited to share his experience with RT-PCR testing, which he termed the “new, slick, fast” testing option for C. diff. In trials, it has been shown to be 99% sensitive and 98% specific. “If your lab does PCR, it is the best test currently available,” Dr. Bartlett said, although he cautioned that “this test detects the bug, not the toxin.”

Treatment of C. diff disease happens in the colon, and medications must make it there to be effective. The most common treatments, vancomycin and metronidazole, have pluses and minuses, Dr. Bartlett explained. Vancomycin is FDA-approved and unbeaten in clinical trials; however, it is the more expensive choice. Metronidazole is cheaper ($5 per day) and proven to be effective in mild to moderate cases, but is not FDA-approved and is unproven in severe cases.

Dr. Bartlett’s guidelines for C. diff treatment:

  • Mild cases: no treatment;
  • Moderate: metronidazole 250 mg four times a day for 10 to 14 days; and
  • Serious: vancomycin 125 mg four times a day for 10 to 14 days.

“If metro doesn’t work, switch to oral vanco,” Dr. Bartlett said. HM10

More from the HM10 Special Report

National Imperative

Hospitalists challenged to keep making healthcare better

ONLINE EXCLUSIVE: Audio interview with SHM President Jeff Wiese

SHM's new president talks about his vision for the next generation of hospitalists

Quality Control

As specialty matures, annual meeting flourishes with practical, educational, and social takeaways

Wachter’s World

HM pioneer says healthcare reform offers HM the chance to define cost savings, QI for future generations

Professional Advice

First-class faculty make HM10 pre-courses highly educational, practical

ONLINE EXCLUSIVE: Audio interview with ABIM Learning Session Director Julius Yang

Dr. Yang discusses the HM10 pre-course that prepares hospitalists for ABIM recertification.

Jam-Packed & Well Worth It

A day in the life of one hospitalist’s annual meeting

ONLINE EXCLUSIVE: Audio interview with Nasim Afsarmanesh

Dr. Afsarmanesh discusses the events of her dawn-to-dusk Day 2 at HM10 in National Harbor, Md.

Core Competencies Lay Pediatric HM Foundation

Framework in place, PHM’s future is in the hands of hospitalists

Special Interests

From IT to education to community issues, hospitalists want to be part of the healthcare solution

WORKSHOP WRAPUP

Practice Management Session

“The Case for Unit-Based Hospitalists: Benefits and Challenges”

Practice Management Session

“Hospitalist NPPs 301—Advanced Concepts”

Practice Management Session

"The Patient Experience: What Hospitalists Need to Know About Measuring, Reporting, and Benchmarking"

Clinical Session

"Controversies in Anticoagulation and Thrombosis"

Quality Session

"The Value Proposition to C-Suites: Aligning Hospital Resources to Support Hospitalist QI"

Quality Session

"Quality Improvement Curriculum: How to Get Started and to Keep Going"


You may also

DOWNLOAD THE COMPLETE HM10 SPECIAL REPORT SUPPLEMENT

in pdf format (2.3 MB).

Next Article:

   Comments ()